利福平与每日服用丙硫异烟胺联合治疗麻风病的肝毒性。 - Suppr | 超能文献

Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy.

作者信息

Ji B H, Chen J K, Wang C M, Xia G A

出版信息

Lepr Rev. 1984 Sep;55(3):283-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Hepatotoxicity of combined therapy with rifampicin and daily prothionamide for leprosy.利福平与每日服用丙硫异烟胺联合治疗麻风病的肝毒性。

Lepr Rev. 1984 Sep;55(3):283-9.

2

Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.每日5毫克/千克丙硫异烟胺+10毫克/千克利福平联合用药的肝毒性。

Int J Lepr Other Mycobact Dis. 1985 Mar;53(1):15-8.

3

Hepatitis and multi-drug therapy in leprosy with special reference to prothionamide.麻风病中的肝炎与多药联合治疗，特别提及丙硫异烟胺。

Indian J Lepr. 1985 Jan-Mar;57(1):78-89.

4

Rifampin drug interactions.利福平的药物相互作用。

Arch Intern Med. 1987 Oct;147(10):1856.

5

The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.

Lepr Rev. 1986;57 Suppl 3:29-37. doi: 10.5935/0305-7518.19860090.

6

Rifampicin and isoprodian in combination in the treatment of leprosy.利福平与异丙安替比林联合治疗麻风病

Lepr Rev. 1975 Jun;46(2 Suppl):179-80. doi: 10.5935/0305-7518.19750063.

7

Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.利福平与异普罗地联合用于麻风病治疗的初步经验。

Lepr Rev. 1975 Jun;46(2 Suppl):189-98. doi: 10.5935/0305-7518.19750065.

8

The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.

Lepr Rev. 1986;57 Suppl 3:63-6. doi: 10.5935/0305-7518.19860096.

9

Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.

Lepr Rev. 1975 Jun;46(2 Suppl):173-8. doi: 10.5935/0305-7518.19750062.

10

First assessment of the Malta Leprosy Eradication Project.

Lepr Rev. 1986;57 Suppl 3:42-6. doi: 10.5935/0305-7518.19860092.

引用本文的文献

1

An international randomized study with long-term follow-up of single versus combination chemotherapy of multibacillary leprosy.一项关于多菌型麻风病单药化疗与联合化疗长期随访的国际随机研究。

Antimicrob Agents Chemother. 1994 Oct;38(10):2249-57. doi: 10.1128/AAC.38.10.2249.

2

Clinical pharmacokinetic considerations in the treatment of patients with leprosy.麻风病患者治疗中的临床药代动力学考量

Clin Pharmacokinet. 1989 Jun;16(6):365-86. doi: 10.2165/00003088-198916060-00003.